VITREORETINAL CONSULTANTS

Ocugen announced a positive 2-year safety and efficacy update for their OCU400 therapy in treating retinitis pigmentosa, showing significant improvement in low-light vision. This breakthrough offers hope for patients with various mutations and paves the way for future retinal disease treatments. Learn more: https://brnw.ch/21wRCFL #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity

Dr. Pamela Weber was featured on the BrightFocus Foundation podcast, discussing treatment options for geographic atrophy, an advanced form of dry age-related macular degeneration. She shares insights on navigating new FDA-approved treatments and supporting those with vision loss. Listen to the full episode here: https://brnw.ch/21wRucf #retinacare #eyehealth #ophthalmology #visioncare #patientcentricity

We are proud to announce that Dr. Charles W. Mango has been promoted to Clinical Professor of Ophthalmology at Weill Cornell Medical College. With over 20 years of expertise in vitreoretinal disorders, Dr. Mango continues to lead the way in both patient care and academic contributions. Congratulations, Dr. Mango, on this well-deserved recognition! #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity

A new study shows that microdrops with phenylephrine and tropicamide are just as effective as standard drops for eye exams in preterm infants, with fewer side effects. This could lead to safer screenings for retinopathy of prematurity (ROP) with better outcomes for these babies. Learn more: https://brnw.ch/21wRjfl #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity

At Vitreoretinal Consultants of NY, we are proud to be leaders in retinal research, contributing to groundbreaking treatments like Lucentis, Avastin, and Eylea. Our commitment to advancing care for retinal diseases through clinical trials helps improve patient outcomes and safety. For more information, contact Kristen D'Amore at [email protected]. #research #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity

This National Nutrition Month, we’re highlighting the important connection between a healthy diet and eye health. Proper nutrition can help protect your retina and prevent conditions like age-related macular degeneration. Fuel your vision with a balanced diet rich in antioxidants, vitamins, and minerals! #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity

The RESTORE study shows that gene therapy with lenadogene nolparvovec helps improve vision for people with LHON caused by the MT-ND4 mutation, and the results last for up to five years. This offers hope for long-term vision recovery and a better quality of life for those affected by this condition. Learn more: https://brnw.ch/21wR6tu #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity

Vitreoretinal Consultants of NY is proud to have the most Castle Connolly-awarded retina specialists in New York. This reflects our team's dedication to excellence in retinal and macular care. We remain committed to providing the highest quality treatment for our patients. #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity

A recent study links aromatic amines in hair dye to retinopathy, with symptoms resembling MEK inhibitor-associated retinopathy. In three cases, women developed bilateral serous retinal detachments (SRDs) after hair dye use, which resolved after discontinuing the dye. This highlights the importance of considering RAHDAA in diagnoses when visual disturbances occur after hair dye exposure. https://lnkd.in/eMMJG-ag #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity

Nona Biosciences has partnered with Kodiak Sciences to develop innovative multi-target antibodies for ophthalmic diseases. Using Nona's Harbour Mice platform, the collaboration aims to accelerate the discovery of cutting-edge therapies for retinal and other eye conditions, advancing treatment options for complex diseases. https://lnkd.in/e9VMtC_i #retinacare #retinahealth #eyehealth #ophthalmology #visioncare #eyehealth #retinaspecialist #patientcentricity